Differentiating agent, hexamethylene bisacetamide, inhibits neointimal formation after vascular injury. 1997

S Ishikawa, and S Hori, and M Kusuhara, and Y Kanai, and S Handa, and K Yamaguchi, and Y Hosoda, and S Ogawa
Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan.

BACKGROUND Hexamethylene bisacetamide (HMBA), a potent differentiating agent of transformed cell lines, has been reported to affect phenotypic modulation and suppress proliferation of vascular smooth muscle cells (VSMCs). The effects of HMBA on the growth of VSMCs were studied in the rat carotid injury model. METHODS HMBA was added to culture medium of VSMCs explanted from aorta of Sprague Dawley rats and the cell number was counted after 5 days of incubation. The carotid artery of Sprague Dawley rats was denuded with a balloon embolectomy catheter. The rats were treated with continuous infusion of HMBA (1 g/day) or saline for 7 days after injury. RESULTS HMBA inhibited VSMC proliferation in a dose-dependent manner (at a HMBA concentration of 1-5 mM). Plasma concentration of HMBA during continuous infusion was in the range 0.8-1.0 mM. Immunohistochemistry of proliferating cell nuclear antigen showed that HMBA inhibited VSMC proliferation after vascular injury. Cell number in the intima and neointimal thickening were significantly reduced in HMBA-treated rats at 14 days after injury. CONCLUSIONS Systemic administration of HMBA inhibited VSMC proliferation in the rat carotid injury model.

UI MeSH Term Description Entries
D008297 Male Males
D009131 Muscle, Smooth, Vascular The nonstriated involuntary muscle tissue of blood vessels. Vascular Smooth Muscle,Muscle, Vascular Smooth,Muscles, Vascular Smooth,Smooth Muscle, Vascular,Smooth Muscles, Vascular,Vascular Smooth Muscles
D010976 Platelet Count The number of PLATELETS per unit volume in a sample of venous BLOOD. Blood Platelet Count,Blood Platelet Number,Platelet Number,Blood Platelet Counts,Blood Platelet Numbers,Count, Blood Platelet,Count, Platelet,Counts, Blood Platelet,Counts, Platelet,Number, Blood Platelet,Number, Platelet,Numbers, Blood Platelet,Numbers, Platelet,Platelet Count, Blood,Platelet Counts,Platelet Counts, Blood,Platelet Number, Blood,Platelet Numbers,Platelet Numbers, Blood
D002404 Catheterization Use or insertion of a tubular device into a duct, blood vessel, hollow organ, or body cavity for injecting or withdrawing fluids for diagnostic or therapeutic purposes. It differs from INTUBATION in that the tube here is used to restore or maintain patency in obstructions. Cannulation,Cannulations,Catheterizations
D002452 Cell Count The number of CELLS of a specific kind, usually measured per unit volume or area of sample. Cell Density,Cell Number,Cell Counts,Cell Densities,Cell Numbers,Count, Cell,Counts, Cell,Densities, Cell,Density, Cell,Number, Cell,Numbers, Cell
D002455 Cell Division The fission of a CELL. It includes CYTOKINESIS, when the CYTOPLASM of a cell is divided, and CELL NUCLEUS DIVISION. M Phase,Cell Division Phase,Cell Divisions,Division Phase, Cell,Division, Cell,Divisions, Cell,M Phases,Phase, Cell Division,Phase, M,Phases, M
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D000081 Acetamides Derivatives of acetamide that are used as solvents, as mild irritants, and in organic synthesis.
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D016893 Carotid Stenosis Narrowing or stricture of any part of the CAROTID ARTERIES, most often due to atherosclerotic plaque formation. Ulcerations may form in atherosclerotic plaques and induce THROMBUS formation. Platelet or cholesterol emboli may arise from stenotic carotid lesions and induce a TRANSIENT ISCHEMIC ATTACK; CEREBROVASCULAR ACCIDENT; or temporary blindness (AMAUROSIS FUGAX). (From Adams et al., Principles of Neurology, 6th ed, pp 822-3) Carotid Artery Narrowing,Carotid Ulcer,Carotid Artery Plaque,Carotid Artery Stenosis,Carotid Artery Ulcerating Plaque,Common Carotid Artery Stenosis,External Carotid Artery Stenosis,Internal Carotid Artery Stenosis,Plaque, Ulcerating, Carotid Artery,Stenosis, Common Carotid Artery,Stenosis, External Carotid Artery,Ulcerating Plaque, Carotid Artery,Artery Narrowing, Carotid,Artery Narrowings, Carotid,Artery Plaque, Carotid,Artery Plaques, Carotid,Artery Stenoses, Carotid,Artery Stenosis, Carotid,Carotid Artery Narrowings,Carotid Artery Plaques,Carotid Artery Stenoses,Carotid Stenoses,Carotid Ulcers,Narrowing, Carotid Artery,Narrowings, Carotid Artery,Plaque, Carotid Artery,Plaques, Carotid Artery,Stenoses, Carotid,Stenoses, Carotid Artery,Stenosis, Carotid,Stenosis, Carotid Artery,Ulcer, Carotid,Ulcers, Carotid

Related Publications

S Ishikawa, and S Hori, and M Kusuhara, and Y Kanai, and S Handa, and K Yamaguchi, and Y Hosoda, and S Ogawa
April 2016, Cancer research,
S Ishikawa, and S Hori, and M Kusuhara, and Y Kanai, and S Handa, and K Yamaguchi, and Y Hosoda, and S Ogawa
January 1989, Drug metabolism and disposition: the biological fate of chemicals,
S Ishikawa, and S Hori, and M Kusuhara, and Y Kanai, and S Handa, and K Yamaguchi, and Y Hosoda, and S Ogawa
March 1987, Journal of chromatography,
S Ishikawa, and S Hori, and M Kusuhara, and Y Kanai, and S Handa, and K Yamaguchi, and Y Hosoda, and S Ogawa
October 1986, Cancer research,
S Ishikawa, and S Hori, and M Kusuhara, and Y Kanai, and S Handa, and K Yamaguchi, and Y Hosoda, and S Ogawa
August 1986, Cancer treatment reports,
S Ishikawa, and S Hori, and M Kusuhara, and Y Kanai, and S Handa, and K Yamaguchi, and Y Hosoda, and S Ogawa
December 1990, Journal of the National Cancer Institute,
S Ishikawa, and S Hori, and M Kusuhara, and Y Kanai, and S Handa, and K Yamaguchi, and Y Hosoda, and S Ogawa
February 1994, Journal of chromatography,
S Ishikawa, and S Hori, and M Kusuhara, and Y Kanai, and S Handa, and K Yamaguchi, and Y Hosoda, and S Ogawa
November 1999, Journal of cardiovascular pharmacology,
S Ishikawa, and S Hori, and M Kusuhara, and Y Kanai, and S Handa, and K Yamaguchi, and Y Hosoda, and S Ogawa
September 2019, Atherosclerosis,
S Ishikawa, and S Hori, and M Kusuhara, and Y Kanai, and S Handa, and K Yamaguchi, and Y Hosoda, and S Ogawa
January 2009, Journal of vascular research,
Copied contents to your clipboard!